CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Contingent Consideration Classified as Equity, Fair Value Disclosure
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Contingent Consideration Classified as Equity, Fair Value Disclosure of $2.83 million as of 2015-06-27, per its 10-Q filed 2015-07-30.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure · last filed 2015-07-30
- 2015-06-27: Contingent Consideration Classified as Equity, Fair Value Disclosure $2.83M.
- 2015-03-28: Contingent Consideration Classified as Equity, Fair Value Disclosure $2.79M.
- 2014-12-27: Contingent Consideration Classified as Equity, Fair Value Disclosure $2.83M.
| Period end | Contingent Consideration Classified as Equity, Fair Value Disclosure |
|---|---|
| 2015-06-27 | $2.83M 10-Q · filed 2015-07-30 |
| 2015-03-28 | $2.79M 10-Q · filed 2015-04-30 |
| 2014-12-27 | $2.83M 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |